Extended relief dosage form
AssigneeThe Procter & Gamble Company
InventorsMark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Anness, Guhan Balan, Andrew Nicholas Carr
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Procter & Gamble Company
InventorsMark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Anness, Guhan Balan, Andrew Nicholas Carr
Estimating the term…
A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.
A dosage form comprising:
A dosage form comprising:
Dependencies are inferred from the claim text.